Clinical trial
Ambisome in Liver Transplant Patients
NCT00161356 · The University of Texas Health Science Center, Houston, Other · Terminated
Key facts
| NCT number | NCT00161356 |
|---|---|
| Title | Ambisome in Liver Transplant Patients |
| Official title | Blood, Bile and Tissue Pharmacokinetics of Single Dose Liposomal Amphotericin B (AmBisome ®) in Liver Transplant Patients. |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug, Procedure |
| Interventions | Ambisome, Liver Biopsy |
| Enrollment | 10 |
| Start date | Sep 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 23, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: